(Q37841742)

24 August 2017

1 reference

title

Epstein criteria for insignificant prostate cancer (English)

1 reference

24 August 2017

1 reference

Sheng F Oon

1

1 reference

24 August 2017

R William Watson

series ordinal

2

1 reference

24 August 2017

John J O'Leary

series ordinal

3

1 reference

24 August 2017

John M Fitzpatrick

series ordinal

4

1 reference

24 August 2017

14 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

108

1 reference

24 August 2017

518-525

1 reference

24 August 2017

4

1 reference

International trends in prostate-cancer mortality in the "PSA ERA".

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Screening for prostate cancer: a Cochrane systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

An update of the Gleason grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.09979.X

10.1111/J.1464-410X.2011.09979.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference